Selected Publications

Tozer, G. M., Prise, V. E., Wilson, J., Cemazar, M., Shan, S., Dewhirst, M. W., Barber, P. R., Vojnovic, B. and Chaplin, D. J., 2001. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res, 61, 6413-6422.

Parkins, C.S., Holder, A.J., Hill, S.A., Chaplin, D.J. and Tozer, G.M, 2000. Determinants of anti-vascular action by Combretastatin A-4 phosphate: role of nitric oxide. Br J Cancer, 83, 811-816.

Greco, O., Folkes, L.K., Wardman, P., Tozer, G.M., and Dachs, G.U., 2000. Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Therapy, 7, 1414-1420.

Tozer, G.M., Prise, V.E., Wilson, J., Locke, R.J., Vojnovic, B., Stratford, M.R.L., Dennis, M.F. and Chaplin, D.J., 1999. Combretastatin A-4-phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. Cancer Res, 59, 1626-1634.

Hill, S.A., Collingridge, D. R., Vojnovic, B. and Chaplin, D.J., 1998. Tumour radiosensitization by high-oxygen-content gases: Influence of the carbon dioxide content of the inspired gas on pO2, microcirculatory function and radiosensitivity. Int J Radiat Oncol Biol Phys, 40, 943-951.